[go: up one dir, main page]

DE68912195D1 - Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis. - Google Patents

Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.

Info

Publication number
DE68912195D1
DE68912195D1 DE89304842T DE68912195T DE68912195D1 DE 68912195 D1 DE68912195 D1 DE 68912195D1 DE 89304842 T DE89304842 T DE 89304842T DE 68912195 T DE68912195 T DE 68912195T DE 68912195 D1 DE68912195 D1 DE 68912195D1
Authority
DE
Germany
Prior art keywords
treatment
pyrrolicloncarboxylic
ichthyosis
medicament
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE89304842T
Other languages
English (en)
Other versions
DE68912195T2 (de
Inventor
Ian Richard Scott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever NV
Original Assignee
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever NV filed Critical Unilever NV
Publication of DE68912195D1 publication Critical patent/DE68912195D1/de
Application granted granted Critical
Publication of DE68912195T2 publication Critical patent/DE68912195T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE68912195T 1988-05-13 1989-05-12 Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis. Expired - Lifetime DE68912195T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888811410A GB8811410D0 (en) 1988-05-13 1988-05-13 Treatment of skin disorders

Publications (2)

Publication Number Publication Date
DE68912195D1 true DE68912195D1 (de) 1994-02-24
DE68912195T2 DE68912195T2 (de) 1994-05-19

Family

ID=10636883

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68912195T Expired - Lifetime DE68912195T2 (de) 1988-05-13 1989-05-12 Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.

Country Status (10)

Country Link
US (1) US5045559A (de)
EP (1) EP0342055B1 (de)
JP (1) JPH0217122A (de)
AT (1) ATE99932T1 (de)
AU (1) AU617466B2 (de)
CA (1) CA1324760C (de)
DE (1) DE68912195T2 (de)
ES (1) ES2061989T3 (de)
GB (1) GB8811410D0 (de)
ZA (1) ZA893563B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2016351C (en) * 1989-05-12 1996-09-03 Walter Thomas Gibson Cosmetic composition
US5455036A (en) * 1990-06-29 1995-10-03 Bode Chemie Method of using cis-urocaninic acid for topically treating psoriasis
US5286720A (en) * 1992-07-16 1994-02-15 Solarcare Technologies Corporation Compositions and methods for topical treatment of skin lesions
GB2313546B (en) * 1993-03-29 1998-01-21 Bioglan Ireland Pharmaceutically useful imidazolyl derivatives
US5583118A (en) * 1993-08-04 1996-12-10 Patent Biopharmaceutics, Inc. Method of treating an anorectal disease using hyaluronic acid-urea pharmaceutical compositions
US5776920A (en) * 1995-08-02 1998-07-07 Quarles; Ruth Method for treatment of psoriasis
FR2742750B1 (fr) * 1995-12-22 1998-01-30 Oreal Nouveaux derives de l'acide l-2-oxothiazolidine 4-carboxylique et leur utilisation pour le soin de la peau
ITMI20052077A1 (it) * 2005-10-31 2007-05-01 Roda S R L Agente batteriostatica e-o battericida per preparazioni cosmetiche e-o dermofarmaceutiche e preparazioni contenenti questo agente
MX352434B (es) * 2007-03-22 2017-11-24 Berg Llc Formulaciones topicas que tienen biodisponibilidad aumentada.
JP5352100B2 (ja) * 2008-03-12 2013-11-27 株式会社 資生堂 皮膚外用組成物
ES2336995B1 (es) * 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
JP5903735B2 (ja) 2009-05-11 2016-04-13 バーグ エルエルシー エピメタボリックシフター（コエンザイムｑ１０）を使用した疾患の処置方法
US9486192B2 (en) 2009-07-28 2016-11-08 St. Jude Medical Puerto Rico Llc Vascular closure device with automatic suture cutter
EA032941B1 (ru) * 2010-03-12 2019-08-30 БЕРГ ЭлЭлСи ЛЕКАРСТВЕННЫЕ ФОРМЫ КОЭНЗИМА Q10 (CoQ10) ДЛЯ ВНУТРИВЕННОГО ВВЕДЕНИЯ И ИХ ПРИМЕНЕНИЕ
US8846723B2 (en) 2010-07-29 2014-09-30 Eastman Chemical Company Esters of O-substituted hydroxy carboxylic acids and preparations thereof
US8613940B2 (en) 2010-09-03 2013-12-24 Eastman Chemical Company Carbonate derivatives as skin care
US8329938B2 (en) 2011-02-21 2012-12-11 Eastman Chemical Company Hydroxyalkanoic acid and hydroxyalkanoice acid oligomer esters of retinol
EP2694463B8 (de) 2011-04-04 2019-10-09 Berg LLC Behandlung von tumoren im zentralnervensystem mit coenzym q10
US10973763B2 (en) 2011-06-17 2021-04-13 Berg Llc Inhalable pharmaceutical compositions
US9259343B2 (en) 2012-07-06 2016-02-16 Newman Technologies LLC Device for mitigating plantar fasciitis
ES2825083T3 (es) 2013-09-04 2021-05-14 Berg Llc Métodos de tratamiento contra el cáncer mediante infusión continua de coenzima Q10
US20170189350A1 (en) 2015-11-16 2017-07-06 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3235457A (en) * 1962-12-07 1966-02-15 Gillette Co Humectant
DE2102172C3 (de) * 1971-01-18 1980-03-20 Dr. Karl Thomae Gmbh, 7950 Biberach Neue Mittel zur Behandlung und Pflege der Haut
DE2102171A1 (en) * 1971-01-18 1972-07-27 Dr. Karl Thomae Gmbh, 7950 Biberach Pyrrolidonecarboxylic acid alkyl esters - cosmetic agents
JPS4882046A (de) * 1972-02-02 1973-11-02
JPS536217B2 (de) * 1972-11-30 1978-03-06
LU74438A1 (de) * 1976-02-26 1977-09-12
JPS57185209A (en) * 1981-05-11 1982-11-15 Nisshin Oil Mills Ltd:The Esterified composition and cosmetic containing the same
JPS60214744A (ja) * 1984-04-06 1985-10-28 Nitto Electric Ind Co Ltd 薬物の経皮吸収促進助剤及びこれを含有する外用医薬組成物
GB8421112D0 (en) * 1984-08-20 1984-09-26 Unilever Plc Pyroglutamic acid esters
US4772601A (en) * 1988-01-25 1988-09-20 Hoechst-Roussel Pharmaceuticals, Inc. 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use

Also Published As

Publication number Publication date
JPH0217122A (ja) 1990-01-22
ATE99932T1 (de) 1994-01-15
EP0342055B1 (de) 1994-01-12
GB8811410D0 (en) 1988-06-15
EP0342055A3 (en) 1990-08-29
EP0342055A2 (de) 1989-11-15
DE68912195T2 (de) 1994-05-19
ES2061989T3 (es) 1994-12-16
AU3459689A (en) 1989-11-16
AU617466B2 (en) 1991-11-28
ZA893563B (en) 1991-01-30
CA1324760C (en) 1993-11-30
US5045559A (en) 1991-09-03

Similar Documents

Publication Publication Date Title
DE68912195D1 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
ATE82121T1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
DE3772139D1 (de) Kosmetische zusammensetzung.
DE69418601D1 (de) Guanidinderivate mit therapeutischer wirkung
DE69029100D1 (de) Verwendung von Ketoconazol und ein Retinoid zur Behandlung der Akne vulgaris
SE9604486D0 (sv) Novel formulation
FI950909A0 (fi) Rasvahappojohdannaisia
EP0214254A1 (de) Melatoninhaltige mittel sowie deren verwendungen.
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
DK0631772T3 (da) Retinoidholdig sammensætning
BG104470A (en) The use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases
DE69635298D1 (de) Verwendung von Acetylsalicylsäuren zur Herstellung eines Medikaments für die Behandlung von Hautverletzungen
DE59409394D1 (de) Therapeutisches system zur behandlung der psoriasis
MX9304185A (es) Producto y composicion farmaceutica que lo contiene para el tratamiento de la mastitis y la mestritis bovina.
DE69313261D1 (de) Verwendung von LACTOFERRIN zur Herstellung eines THERAPEUTISCHEN MITTELS zur Behandlung von RHEUMATISMUS
ATE69949T1 (de) Liposomen mit inhalativen allergenen zur behandlung von allergien, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
ATE173921T1 (de) Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen
DE69825322D1 (de) Topische carbamazepin-formulierungen und deren verwendung
KR920009403A (ko) 수면장해 치료용 이미다조벤조디아제핀
RU94004116A (ru) Способ лечения розовых угрей
HK1004889A1 (en) Pharmaceutical formulations containing vincamine for treatment of peripheral vascular diseases
GEU1997304Y (en) Ointment for Treatment of Skin Fungous Diseases

Legal Events

Date Code Title Description
8364 No opposition during term of opposition